The FDA has approved the use of a blood test to determine if patients have a protein that is prevalent in Alzheimer’s disease.
Alisa Nelson talks to Sarah Lovegreen, with the Greater Missouri chapter of the Alzheimer’s Association, who says the new tool is one step in helping to determine if someone has the disease.